- Home
- NRC vs PACB Comparison
NRC vs PACB Comparison
Compare NRC & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRC | PACB |
|---|---|---|
| Founded | 1981 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 504.8M | 521.8M |
| IPO Year | 1997 | 2010 |
Fundamental Metrics
Financial Performance| Metric | NRC | PACB |
|---|---|---|
| Price | $22.30 | $1.47 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $1.67 |
| AVG Volume (30 Days) | 102.1K | ★ 5.9M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.86% | N/A |
| EPS Growth | ★ 4707.69 | N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $119,686,000.00 | $93,468,000.00 |
| Revenue This Year | N/A | $11.32 |
| Revenue Next Year | N/A | $12.14 |
| P/E Ratio | $157.50 | ★ N/A |
| Revenue Growth | 1.81 | ★ 3.04 |
| 52 Week Low | $11.01 | $1.09 |
| 52 Week High | $23.00 | $2.73 |
Technical Indicators
Market Signals| Indicator | NRC | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 61.02 | 47.40 |
| Support Level | $16.74 | $1.29 |
| Resistance Level | $22.90 | $1.79 |
| Average True Range (ATR) | 0.96 | 0.12 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 68.71 | 6.49 |
Price Performance
Historical ComparisonAbout NRC National Research Corporation (Delaware)
NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.